Free Trial

Burning Rock Biotech (BNR) SEC Filings & 10K Form

Burning Rock Biotech logo
$4.52 -0.18 (-3.83%)
Closing price 03/28/2025 03:58 PM Eastern
Extended Trading
$4.57 +0.05 (+1.11%)
As of 03/28/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Burning Rock Biotech SEC Filings

DateFilerForm TypeView
03/25/2025
7:14 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/31/2024
5:05 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2024
5:06 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
7:24 AM
Burning Rock Biotech (Filer)
Form 20-F/A
11/14/2024
11:29 AM
Burning Rock Biotech (Subject)
Kynam Capital Management, LP (Filed by)
Form SC 13G/A
09/27/2024
8:15 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
6:27 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
12:59 PM
Burning Rock Biotech (Filer)
Form 424B3
09/06/2024
5:16 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2024
5:06 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
5:04 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
5:08 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
5:05 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
5:06 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
5:17 AM
Burning Rock Biotech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/26/2024
7:30 AM
Burning Rock Biotech (Subject)
Form F-6 POS
04/26/2024
7:30 AM
Burning Rock Biotech (Subject)
Citibank,N.A./ADR (Filed by)
Citibank,N.A./ADR (Filed by)
Form F-6 POS
04/26/2024
5:06 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:BNR) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners